Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
ICMR teams with private firms to develop typhoid and paratyphoid vaccines, targeting India's high infection rates.
The Indian Council of Medical Research (ICMR) is collaborating with private companies to develop and commercialize a vaccine for typhoid and paratyphoid.
The ICMR aims to validate and develop the vaccine against pathogens like Salmonella Typhi and Paratyphi, with selected companies paying a 2% royalty on sales.
India had around 10 million typhoid cases in 2021, the highest globally.
The ICMR will provide technical support throughout development and commercialization phases.
4 Articles
ICMR trabaja en equipo con empresas privadas para desarrollar vacunas tifoideas y paratifoideas, dirigidas a las altas tasas de infección de la India.